Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001610520-24-000138·ASLAN Pharmaceuticals Ltd
Schedule 13G ownership disclosure
ASLAN PHARMACEUTICALS LT ADR
Ordinary Shares as represented by American Depository Shares (ADSs),par value $0.01 per ordinary share · CUSIP: 04522R309
Event date: 2024-06-30
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- UBS Group AG
Shares: Unavailable · Class: Unavailable
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001610520-24-000138
- Form type
- SCHEDULE 13G/A
- Filer
- ASLAN Pharmaceuticals Ltd
- CIK
- CIK 1722926
- Filed
- Aug 08, 2024
- Reporting period
- Jun 30, 2024
- Description
- Schedule 13G beneficial ownership